“Designer Babies?” No, But This New Genetic Test Could Change IVF Forever

What if you could know your future child’s risk for serious genetic conditions before pregnancy even begins?

That’s precisely what new technology from Orchid Genetics is making possible through whole-genome embryo screening. This initiative isn’t about “designer babies.” It’s about giving families real, actionable information to make the most informed choices on their fertility journey, offering a new level of hope and optimism. In simple terms, this technology enables us to examine the entire genetic information of an embryo before implantation, helping us understand the potential health outcomes of the future child.

In our latest podcast episode, SMARTPath Fertility Intl. founder Maria Feekes had the honor of speaking with Maria Katz, a compassionate and deeply knowledgeable genetic counselor at Orchid Genetics. Maria is at the forefront of this groundbreaking approach that allows embryos created via IVF to be screened for over 1,200 genetic conditions.

Her expertise and experience in genetic counseling make her the perfect person to guide us through this complex but fascinating topic.

• Neurodevelopmental disorders

• Hereditary cancers

• Cardiovascular risks

• And much more

Click here to watch and listen to the podcast:

What makes this a game-changer in fertility?

Traditional embryo testing (like PGT-A or PGT-M) often looks at a limited set of conditions or chromosomal issues. However, whole-genome screening goes far beyond that, providing a comprehensive view and unlocking deeper insights into potential health outcomes based on family history and known genetic markers, thereby giving families a sense of reassurance and confidence in their decisions.

Maria breaks it down beautifully in our conversation:

• The limitations of current embryo testing

• How Orchid’s technology works

• What families should know before starting IVF

• We shouldn’t overlook the ethical and emotional conversations that accompany this powerful knowledge. They are crucial aspects that we, as a society, need to consider and address, making us feel responsible and considerate in our use of this technology.

Is This the Future of Reproductive Health?

While this technology creates new opportunities, it also prompts crucial inquiries: 'How much information is too much?' 

👉 What are the emotional impacts of knowing potential risks? 

👉 How do we ensure informed consent and ethical use?

These are not just questions but responsibilities that we, as a society, need to consider and address, making us feel responsible and considerate.

Maria doesn’t shy away from these topics. Her balanced, compassionate approach is what makes this episode vital.

“This isn’t about perfection. It’s about giving people options and helping them plan with clarity,” Maria says.

Who Should Listen?

This episode is a must for:

 💡 Families navigating IVF

 💡 Anyone considering embryo screening

 💡 Fertility professionals and reproductive health advocates

 💡 Curious minds watching the intersection of genetics, ethics, and innovation

Listen now! https://www.youtube.com/watch?v=7PmVVcVTgZ4